Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
08/2003
08/28/2003WO2003070767A1 Tissue specific expression
08/28/2003WO2002024876A3 Live influenza vaccine and method of manufacture
08/28/2003US20030162170 Nucleic acids; antibody, antigen complex
08/28/2003US20030161845 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
08/27/2003EP1337656A1 In vitro generation of recombinant adenovirus vectors
08/27/2003EP1337655A2 Retroviral vectors containing internal ribosomal entry sites
08/27/2003EP1337646A2 Genes of the 1-desoxy-d-xylulose biosynthesis path
08/27/2003EP1337641A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
08/27/2003EP1337627A2 Method for purifying adenoviruses
08/27/2003EP1337626A2 Bacteriophage composition useful in treating food products to prevent bacterial contamination
08/27/2003EP0821693B1 Novel human cytomegalovirus dna sequences
08/27/2003CN1439056A Herpes viruses for immune modulation
08/26/2003US6610522 Cloned genes encoding reverse transcriptase lacking RNase H activity
08/26/2003US6610474 Cells for detection of influenza and parainfluenza viruses
08/26/2003US6610305 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
08/26/2003US6610303 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them
08/26/2003US6610290 Transferring preferential nucleotide sequences to cells; obtain cells, incubate with expression vector, transform cells, recover transformed cells
08/21/2003WO2003068993A1 Method for isolation and purification of expressed gene products in vitro
08/21/2003WO2003068954A2 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003WO2003068933A2 Optimization of gene sequences of virus-like particles for expression in insect cells
08/21/2003WO2003068923A2 Signal for packaging of influenza virus vectors
08/21/2003WO2003068809A2 An herpes simplex virus complex
08/21/2003WO2003068804A2 Novel insect cell line
08/21/2003WO2003068163A2 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
08/21/2003WO2003067991A1 Compositions and methods for treatment of microbial infections
08/21/2003WO2003046138A3 Genetically stable expression vector
08/21/2003WO2002077210A3 Methods to culture circovirus
08/21/2003WO2002072140A3 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro
08/21/2003WO2002067861A3 Oncolytic adenoviral vectors
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158141 Comprising virus, non-coding regulatory region of which is replaced by heterologous encoding sequence, wherein function of replaced regulatory region is dependent upon secondary structure and wherein encoding sequence has said function
08/21/2003US20030157718 Expression of heterologous genes from an IRES translational cassette in retroviral vectors
08/21/2003US20030157704 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
08/21/2003US20030157703 Recombinant herpesvirus of turkeys and use thereof
08/21/2003US20030157693 Cell lines with latent immunodeficiency virus and methods of use thereof
08/21/2003US20030157692 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof
08/21/2003US20030157689 Plasmid capable of-directly transfecting cell and expressing nidovirales virus; gene therapy; veterinary medicine; genetic vaccines; immunotherapy
08/21/2003US20030157660 Non-M, non-O HIV-1 strains, fragments and uses
08/21/2003US20030157479 Antigen arrays for treatment of allergic eosinophilic diseases
08/21/2003US20030157131 Interferon inducing genetically engineered attenuated viruses
08/21/2003US20030157130 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging
08/21/2003US20030157128 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen
08/21/2003US20030157066 Compositions comprising viruses and methods for concentrating virus preparations
08/21/2003US20030157064 Actin gene promoter; genetic engineered polypeptide; cardiovascular disorders
08/21/2003CA2816242A1 Signal for packaging of influenza virus vectors
08/21/2003CA2513198A1 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003CA2492097A1 Signal for packaging of influenza virus vectors
08/20/2003EP1336652A1 Cells to be used in producing virus vector, process for producing the same and process for producing virus vector with the use of the cells
08/20/2003EP1336088A2 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium
08/20/2003EP1335987A2 Modified vaccinia ankara virus variant
08/20/2003CN1437655A Assembly of wild-type and chimeric influenza virus-like particles (VLPS)
08/20/2003CN1437613A Modified morbillivirus V proteins
08/20/2003CN1118569C (-)-strand RNA virus vector having autonomously replicating activity
08/19/2003CA2012414C Hog cholera virus vaccine and diagnostic
08/14/2003WO2003066868A1 Retroviral vectors pseudotyped with influenza virus hemagglutinin for gene delivery
08/14/2003WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003WO2003066663A2 Peptides for recognition and targeting of glial cell tumors
08/14/2003WO2003066093A1 A continuous cell line for the production of vaccines
08/14/2003WO2003047617A3 Vaccine
08/14/2003WO2002072803A3 Subgenomic replicons of the flavivirus dengue
08/14/2003WO2002039116A3 Retrovirus isolated from humans
08/14/2003WO2002020051A3 Equine infectious anemia challenge model for testing vaccines, diagnostics and treatments
08/14/2003WO2002018609A9 Methods for stable transduction of cells with viral vectors
08/14/2003US20030154511 Plant retroviral polynucleotides and methods for use thereof
08/14/2003US20030153081 Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/14/2003US20030153066 Isolating nucleic acid putatively encoding the viral gene from the viral genome; programming a cell-free translation system with such nucleic acid, determine if capsid assembly has occurred which indicates that viral gene is required
08/14/2003US20030153065 A formulation for maintaining a non-enveloped viral vector containing: trehalose, magnesium chloride, a cationic polymer or a combination, a multiple of non-enveloped viral vector particles and a liquid carrier
08/14/2003US20030152940 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography
08/14/2003US20030152914 From adeno-associated virus; for treatment of acute conditions requiring rapid gene expression
08/14/2003US20030152912 Multiple viral replicon culture systems
08/14/2003US20030152594 Immunology response intensifiers; administering a bacterial lysate
08/14/2003US20030152592 Genetic engineering hybrid protein
08/14/2003US20030152590 Virion protein; induce immunology response; genetic engineered Dna
08/14/2003US20030152589 Infecting with bacteriophage; inducting immunology response; forming antibodies
08/14/2003CA2475446A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003CA2475326A1 A continuous cell line for the production of vaccines
08/14/2003CA2475101A1 Recombinant bovine immunodeficiency virus based gene transfer system
08/13/2003EP1335023A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
08/13/2003EP1334200A2 Multiple inducible gene regulation system
08/13/2003EP1334174A2 Paramyxovirus vector for gene transfer to the cardiovascular system
08/13/2003EP1334118A2 Methods and reagents for regulation of cellular responses in biological systems
08/13/2003EP0575491B1 Genetically engineered vaccine strain
08/12/2003US6605460 Avian pneumovirus vaccine
08/12/2003US6605282 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
08/07/2003WO2003064666A1 Adenoviral vectors for modulating the cellular activities associated with pods
08/07/2003WO2003064665A2 Viral vector
08/07/2003WO2003064644A1 Method of line retro-position
08/07/2003WO2003064595A2 Recombinant herpesvirus of turkeys and use thereof
08/07/2003WO2003063888A1 Antiviral compositions and methods for identification and use
08/07/2003WO2003063783A2 Multiple virus replicon culture systems
08/07/2003WO2003063725A2 Methods of preventing and treating flavivirus infection in animals
08/07/2003WO2003063679A2 Hepatitis e virus clones and methods of their use
08/07/2003WO2003054199A3 Phytases and method for producing these phytases
08/07/2003WO2002092825B1 Retroviral vectors for gene therapy
08/07/2003US20030148985 Methods and reagents for the inhibition of hepatitis B virus replication
08/07/2003US20030148522 Equine infectious anemia viral plasmid for transfection of heterologous genes into mammalian cells
08/07/2003US20030148521 Conditionally replicative and conditionally active viruses
08/07/2003US20030148509 Retrovirus isolated from humans
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 267